• Profile
Close

Dexmedetomidine vs midazolam on cough and recovery quality after partial and total laryngectomy – A randomized controlled trial

BMC Anesthesiology Oct 02, 2020

Xu R, Zhu Y, Lu Y, et al. - Researchers conducted this prospective, randomized, double-blind, single-center clinical trial to compare the influences of dexmedetomidine and midazolam on hemodynamics and recovery after partial and total laryngectomy. American Society of Anesthesiologist physical status III and IV male adults undergoing elective laryngectomy were selected and allocated randomly to obtain either dexmedetomidine (group D) or midazolam (group M). At the points of wakefulness and departure, the prevalence of no coughing was significantly higher in group D than in group M. Dexmedetomidine is an effective option compared with midazolam to attenuate coughing and hemodynamic changes with a low incidence of adverse outcomes following partial and complete laryngectomy after emergence from anesthesia.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay